Opthea share price was 35c last year, ran up to $1.10, peaked market cap at $1.3B, with no revenue. They also have US$170m debt. At 60c/share, their enterprise value is still ~$830m.
Currently NEU's enterprise value is $1,220m. That's crazy, as NEU has annual royalty income of ~$65m from US market alone, and three advanced indications.
all imo.
- Forums
- ASX - By Stock
- NEU
- Share Price
NEU
neuren pharmaceuticals limited
Add to My Watchlist
5.71%
!
$14.07

Share Price, page-14573
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
$14.07 |
Change
0.760(5.71%) |
Mkt cap ! $1.745B |
Open | High | Low | Value | Volume |
$13.50 | $14.13 | $12.96 | $5.516M | 401.7K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
4 | 77 | $14.06 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$14.08 | 359 | 6 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 1 | 14.030 |
7 | 252 | 14.020 |
4 | 616 | 14.010 |
10 | 2655 | 14.000 |
6 | 1200 | 13.990 |
Price($) | Vol. | No. |
---|---|---|
14.040 | 2907 | 7 |
14.050 | 1256 | 5 |
14.060 | 1782 | 6 |
14.070 | 1546 | 7 |
14.080 | 1254 | 5 |
Last trade - 13.18pm 27/06/2025 (20 minute delay) ? |
Featured News
NEU (ASX) Chart |
The Watchlist
PAR
PARADIGM BIOPHARMACEUTICALS LIMITED..
Paul Rennie, MD & Founder
Paul Rennie
MD & Founder
SPONSORED BY The Market Online